...
首页> 外文期刊>Cellular Physiology and Biochemistry >BMPER Enhances Bone Formation by Promoting the Osteogenesis-Angiogenesis Coupling Process in Mesenchymal Stem Cells
【24h】

BMPER Enhances Bone Formation by Promoting the Osteogenesis-Angiogenesis Coupling Process in Mesenchymal Stem Cells

机译:BMPER通过促进间充质干细胞成骨-血管生成偶联过程来增强骨形成。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background/Aims During bone repair and remodeling, osteogenesis is coupled with angiogenesis. Bone morphogenetic protein (BMP) antagonists are important modulators of BMP signaling and bone homeostasis. Several investigations have demonstrated that one ‘BMP antagonist’, BMP-binding endothelial cell precursor-derived regulator (BMPER), participates in the regulation of BMP signaling. In this study, we examined the role of BMPER in the osteogenesis-angiogenesis coupling process. Methods Human bone mesenchymal stem cells (hBMSCs) and human umbilical vein endothelial cells (HUVECs) were used in this experiment. After overexpressing or silencing BMPER with lentiviruses or siRNA, hBMSCs were stimulated by BMP-2, and osteogenic differentiation activity was detected by alkaline phosphatase and alizarin red staining. VEGF and endostatin release were assessed by ELISA. HUVEC migration was detected by the cell scratch test and transwell migration assay, and in vitro angiogenesis was determined by the tube formation assay. Bone formation was assessed using in vivo femoral monocortical defect and ectopic bone formation models. Results BMP-2 upregulated BMPER expression. Overexpression of BMPER remarkably enhanced BMP-2-induced osteogenic differentiation, while suppression of BMPER effectively inhibited this process both in vitro and in vivo. In addition, overexpression of BMPER promoted BMP-2-induced VEGF expression in vitro and vascularization in the ectopic bone formation model. Conclusion BMPER functions as a positive regulator of the osteogenesis-angiogenesis coupling process in hBMSCs, suggesting a novel therapeutic role of BMPER in the regenerative capacity of bone repair.
机译:背景/目的在骨修复和重塑过程中,成骨作用与血管生成结合在一起。骨形态发生蛋白(BMP)拮抗剂是BMP信号传导和骨稳态的重要调节剂。多项研究表明,一种“ BMP拮抗剂”,即结合BMP的内皮细胞前体来源的调节剂(BMPER),参与了BMP信号的调节。在这项研究中,我们检查了BMPER在成骨-血管生成偶联过程中的作用。方法采用人骨间充质干细胞(hBMSCs)和人脐静脉内皮细胞(HUVECs)进行实验。用慢病毒或siRNA过度表达BMPER或使其沉默后,hBMSCs被BMP-2刺激,并通过碱性磷酸酶和茜素红染色检测成骨分化活性。通过ELISA评估VEGF和内皮抑素释放。通过细胞划痕试验和transwell迁移测定法检测HUVEC迁移,并通过管形成测定法测定体外血管生成。使用体内股骨单皮质缺损和异位骨形成模型评估骨形成。结果BMP-2上调BMPER表达。 BMPER的过表达显着增强了BMP-2诱导的成骨分化,而BMPER的抑制在体外和体内均有效地抑制了这一过程。此外,在异位骨形成模型中,BMPER的过表达促进了BMP-2诱导的VEGF在体外的表达和血管化。结论BMPER在hBMSCs中是成骨-血管生成偶联过程的正向调节剂,提示BMPER在骨修复再生能力中具有新的治疗作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号